Envestnet Asset Management Inc. Buys 1,037 Shares of Addus HomeCare Corporation (NASDAQ:ADUS)

Envestnet Asset Management Inc. increased its stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 2.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 43,735 shares of the company’s stock after purchasing an additional 1,037 shares during the quarter. Envestnet Asset Management Inc. owned about 0.24% of Addus HomeCare worth $4,325,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Natixis lifted its position in Addus HomeCare by 111.9% during the 4th quarter. Natixis now owns 250 shares of the company’s stock valued at $31,000 after purchasing an additional 132 shares during the period. Meeder Asset Management Inc. acquired a new position in Addus HomeCare during the 4th quarter valued at about $77,000. Heritage Family Offices LLP raised its position in shares of Addus HomeCare by 6.3% in the 1st quarter. Heritage Family Offices LLP now owns 2,417 shares of the company’s stock valued at $239,000 after acquiring an additional 143 shares during the period. Defined Financial Planning LLC acquired a new stake in shares of Addus HomeCare in the 4th quarter valued at approximately $270,000. Finally, EP Wealth Advisors LLC raised its position in shares of Addus HomeCare by 17.8% in the 4th quarter. EP Wealth Advisors LLC now owns 2,202 shares of the company’s stock valued at $276,000 after acquiring an additional 332 shares during the period. 95.35% of the stock is owned by institutional investors.

Addus HomeCare Stock Performance

Shares of ADUS stock opened at $109.43 on Friday. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.74 and a current ratio of 1.74. The company has a market capitalization of $2.01 billion, a P/E ratio of 24.70, a price-to-earnings-growth ratio of 1.53 and a beta of 0.81. The company’s 50 day moving average price is $112.32 and its two-hundred day moving average price is $109.45. Addus HomeCare Corporation has a 52 week low of $88.96 and a 52 week high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, May 5th. The company reported $1.42 EPS for the quarter, topping the consensus estimate of $1.33 by $0.09. The firm had revenue of $337.71 million for the quarter, compared to the consensus estimate of $341.66 million. Addus HomeCare had a net margin of 6.52% and a return on equity of 9.23%. The business’s quarterly revenue was up 20.3% on a year-over-year basis. During the same period last year, the company posted $1.21 EPS. On average, analysts expect that Addus HomeCare Corporation will post 4.59 earnings per share for the current fiscal year.

Insider Activity

In other news, EVP Michael D. Wattenbarger sold 2,045 shares of Addus HomeCare stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total value of $235,175.00. Following the sale, the executive vice president directly owned 7,796 shares in the company, valued at $896,540. This trade represents a 20.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 4.60% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of analysts recently weighed in on ADUS shares. JMP Securities reiterated a “market outperform” rating and issued a $150.00 price target on shares of Addus HomeCare in a research report on Wednesday, July 16th. Wall Street Zen raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Sunday, June 29th. Finally, Macquarie reissued an “outperform” rating and set a $133.00 price target on shares of Addus HomeCare in a research report on Tuesday, June 10th. Seven analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, Addus HomeCare has an average rating of “Buy” and a consensus target price of $142.57.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.